Skip to Main Content
DeciBio Consulting logo

DeciBio Consulting

 Save

At a Glance

Uppers

“Firm culture, exciting projects, work at the cutting edge of precision medicine.”

“Great culture and team, interesting work, lots of opportunity.”

“The great people, the electric culture, and the sensible work-life balance”

Downers

“As a smaller company we previously experienced some growing pains, but I think we're out of it now.”

“Lack of health/wellness benefits, long hours.”

“Sometimes roles / responsibilities aren't always clearly defined.”

About DeciBio Consulting

DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of precision medicine. 

Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from  incubator-stage start-ups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic  growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of  primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. 

DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). 

Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the  employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine. DeciBio Consulting, LLC recently launched DeciBio Ventures. This venture capital and creation firm invests in and supports ground-breaking companies in the precision medicine space.

In the News

September 2020 – DeciBio Analytics launches Dexter, an expert network marketplace for the life science industry

DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, has launched an expert network marketplace named Dexter. The launch follows Dexter’s successful beta release a year ago. Dexter customers receive market intelligence by leveraging Dexter’s life science expert network for 1:1 interviews and pulse surveys. Dexter offers an end-to-end research project solution, from finding relevant experts and scheduling interviews, to processing payments. The Dexter network spans various life science cohorts including - but not limited to - single-cell genomics, liquid biopsy, pathology, proteomics, and oncology.

September 2020 – DeciBio Consulting Launches Emmes SARS-CoV-2 Testing Database

DeciBio Consulting has launched the Emmes SARS-CoV-2 Testing Database. This Database serves as the latest addition to the market intelligence products already under DeciBio Consulting’s umbrella. Such products include the Emmes Infectious Disease Database, the Emmes Oncology Database, BioMAP (immuno-oncology biomarkers), Marketbooks, Dexter, and BioTrack, among others.

The DeciBio Emmes SARS-CoV-2 Testing Database provides data visualization tools and raw data covering coronavirus testing practices in approximately 400 labs in the United States. This data includes diagnostic and serology testing details at hospital, public health, and commercial reference labs, as well as send-out volumes. This Database aims to provide insights into current testing behavior and trends to measure how the testing industry is responding to the pandemic.

August 2019:  DeciBio expands parental support and professional development benefits

DeciBio has introduced new benefits that offer custom-tailored enrichment opportunities and support for employees. Highlights include:

  • The DeciBio “Intrapreneurship” Program provides eligible employees with customized professional development opportunities via “pet projects” and inter-company experiences throughout the world. 
  • DeciBio’s Parental Support policies support all parents (regardless of gender) as they welcome the birth or adoption of a child. Eligible employees will receive their full salary during the first twelve weeks of any new parent leave. Further, employees will receive their full salary during the first four weeks of any pregnancy disability leave taken during their pregnancy. And, based on each new parent’s unique needs, DeciBio will work with the employee to create a supportive work environment via, e.g., flexibility, part-time employment opportunities, work-from-home opportunities, and wellness room accessibility. 

July 2019:  DeciBio Consulting acquires diagnostic database products from The Emmes Group

DeciBio announced the acquisition of the Emmes Group’s diagnostic database products.  The Emmes Group’s diagnostic database products will provide DeciBio with valuable real-world market intelligence to support DeciBio’s mission to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine industry.  The Emmes MDx Database provides metrics for the most relevant molecular tests and test panels across 1,000 U.S. MDx testing labs.  Emmes Oncology Database offers similar customer level information focused on tissue-based testing in 300 U.S. anatomic pathology labs.

April 2019:  DeciBio welcomes Andrew Aijian, Ph.D., as Partner

At DeciBio, Andrew advises clients on the activities, strategies, and opportunities accompanying the emergence of cancer immunotherapies and has actively expanded DeciBio’s pharma and biotech practice.  Andrew has led projects across a wide variety of segments within the research tools and clinical diagnostics landscapes, including, among others, infectious disease diagnostics, health IT, translational pathology, genomics instruments and reagents, proteomics research tools, and oncology diagnostics and biomarkers.  He has also contributed to multiple market research reports, developed DeciBio’s clinical trial biomarker analysis platform (BioMAP), and advised on the spin-out of DeciBio Analytics.  Andrew first joined DeciBio in 2013, as a Ph.D. intern.  

DeciBio Consulting

10203 Santa Monica Blvd
Suite 400
Los Angeles, CA 90067
Phone: (310) 451-4510

Firm Stats

Employer Type: Private
Partner: Stephane Budel
Partner: David Cavanaugh
Partner: Andrew Aijian
2021 Employees (All Locations): 50

Major Office Locations

Los Angeles, CA
Oakland, CA
Boston, MA

Major Departments & Practices

 

 

  • Strategy Consulting
  • Data Intelligence (DxBooks, Marketbook, BioMAP, TheraTrack, etc.)
  • Venture Capital (DeciBio Ventures)
  • SaaS (Dexter Expert Network, BioTrack)

  • Precision Medicine

  • Pharmaceuticals

  • Clinical Diagnostics
  • Life Science Research Tools
  • Digital Health and Patient Health Technologies

  • Commercial Due Diligence and Portfolio Support